RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Duquesne Family Office LLC's Holding History (CIK: 0001536411)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 906,767 Value ($000) $9 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 906,767 Value ($000) $7 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 1,385,950 Value ($000) $10 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 1,385,950 Value ($000) $9 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 1,385,950 Value ($000) $10,686 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 1,385,950 Value ($000) $14,747 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 273,650 Value ($000) $2,228 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 273,650 Value ($000) $1,959 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 259,941 Value ($000) $4,453 Avg Close $18.82 Range $15.25 - $23.86
Q3 2021
Shares 259,941 Value ($000) $5,981 Avg Close $28.34 Range $17.80 - $42.81